about
Insulin-producing cells derived from human embryonic stem cells: comparison of definitive endoderm- and nestin-positive progenitor-based differentiation strategiesSynergistic effects of metformin with liraglutide against endothelial dysfunction through GLP-1 receptor and PKA signalling pathwayGLP-1 analog liraglutide enhances proinsulin processing in pancreatic β-cells via a PKA-dependent pathway.Activation of glucagon-like peptide-1 receptor inhibits growth and promotes apoptosis of human pancreatic cancer cells in a cAMP-dependent manner.Activation of glucagon-like peptide-1 receptor inhibits tumourigenicity and metastasis of human pancreatic cancer cells via PI3K/Akt pathway.Metformin attenuates fluctuating glucose-induced endothelial dysfunction through enhancing GTPCH1-mediated eNOS recoupling and inhibiting NADPH oxidase.Exenatide exerts direct protective effects on endothelial cells through the AMPK/Akt/eNOS pathway in a GLP-1 receptor-dependent manner.Effect of Levothyroxine on Miscarriage Among Women With Normal Thyroid Function and Thyroid Autoimmunity Undergoing In Vitro Fertilization and Embryo Transfer: A Randomized Clinical Trial.Anti-proliferative effect of rosiglitazone in the human T-lymphocyte leukaemia cell line Jurkat cells.FoxO1 inhibition promotes differentiation of human embryonic stem cells into insulin producing cells.Liraglutide restores angiogenesis in palmitate-impaired human endothelial cells through PI3K/Akt-Foxo1-GTPCH1 pathway.Infarcted cardiac microenvironment may hinder cardiac lineage differentiation of human embryonic stem cells.Liver-derived fibroblast growth factor 21 mediates effects of glucagon-like peptide-1 in attenuating hepatic glucose outputMTA2-mediated inhibition of PTEN leads to pancreatic ductal adenocarcinoma carcinogenicityGlucagon-like peptide-1 promotes α-to-β cell transdifferentiation: How far is it from clinical application?Glucagon receptor antagonism increases mouse pancreatic δ-cell mass through cell proliferation and duct-derived neogenesisAntagonistic Glucagon Receptor Antibody Promotes α-Cell Proliferation and Increases β-Cell Mass in Diabetic Mice
P50
Q34951717-77B75A98-AED9-42C9-B69D-A1D29773B6A9Q37618348-4A745942-74DC-4E9F-923F-52D2C6EC5A5CQ38972726-57E0C71F-91C6-410B-84BB-02ACF6B735B2Q38997962-F03D8107-55D8-42D2-AC7E-C31C140A5004Q39014390-647C2B75-DFDC-4605-9FBF-9AF857A0076EQ46543541-4D94B172-32A9-486E-93A5-1BA673CF2627Q46564566-68C392C1-FDDE-4C1F-BA26-490E311B93F3Q47194488-4CF8D8BB-FB6F-43B2-888A-12795118C022Q47254985-942EBE15-D968-4075-96F7-94A75630C378Q47382142-95B98938-1CB4-43AC-92BD-DFB9D9117C6FQ51365621-3459E25F-2104-4FE0-B372-893613AFC5D1Q53033380-74EC67E6-8B96-45ED-9F8A-1DC2D35F4D0FQ64075913-D837A73B-B569-426B-8789-46CE2E0CBC5AQ64094161-5CC3E07E-B9E4-40AD-997C-DE19FDB9A8CBQ91124662-776004E4-1D1B-4B7A-9C8B-52609BE57914Q92726698-2003BBE1-224A-4906-9473-56366B94CF68Q92774095-D1A34D4A-D939-40DA-8C04-6052EB917FDA
P50
description
investigador
@es
researcher
@en
name
Rui Wei
@en
type
label
Rui Wei
@en
prefLabel
Rui Wei
@en
P31
P496
0000-0002-8838-703X